Arixtra 5.0 mg/0.4 ml, Injektionslösung

7680559370200 CH-55937 B01AX05 06.03.0.
Arixtra 5.0 mg/0.4 ml, Injektionslösung
Arixtra 5.0 mg/0.4 ml, Injektionslösung
Arixtra 5.0 mg/0.4 ml, Injektionslösung
1 / 3
google

Details

Product number
5593703
CPT
-
Packaging group
2
Unit
Spritze(n)
Composition
fondaparinuxum natricum 5 mg, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml.

Articles (1)

Arixtra 5.0 mg/0.4 ml, Injektionslösung
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/03/2025
Professional SmPC
Français
25/03/2025
Professional SmPC
Italien
25/03/2025
Patient information leaflet
Allemand
15/10/2024
Patient information leaflet
Français
15/10/2024
Patient information leaflet
Italien
15/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
1.93 MG Substance HBESI

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
55937
Drug name
Arixtra, Injektionslösung
Galenic form
LSPA
ATC Code
B01AX05
Authorization status
Z
Dispensation category
B
First authorization
25/06/2002
Authorization expiration date
31/12/9999
IT number
06.03.0.
Domain
Human medicine
Field of application
Antikoagulans

Packaging details

Description (FR)
ARIXTRA sol inj 5 mg/0.4ml 2 ser pré 0.4 ml
Description (DE)
ARIXTRA Inj Lös 5 mg/0.4ml 2 Fertspr 0.4 ml
Narcotic (BTM)
No

Other packaging sizes

ARIXTRA sol inj 2.5 mg/0.5ml 2 ser pré 0.5 ml
2 SPRI
View
ARIXTRA sol inj 2.5 mg/0.5ml 10 ser pré 0.5 ml
10 SPRI
View
ARIXTRA sol inj 1.5 mg/0.3ml 10 ser pré 0.3 ml
10 SPRI
View